192 related articles for article (PubMed ID: 18827378)
1. Design and synthesis of cinanserin analogs as severe acute respiratory syndrome coronavirus 3CL protease inhibitors.
Yang Q; Chen L; He X; Gao Z; Shen X; Bai D
Chem Pharm Bull (Tokyo); 2008 Oct; 56(10):1400-5. PubMed ID: 18827378
[TBL] [Abstract][Full Text] [Related]
2. Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro.
Chen L; Gui C; Luo X; Yang Q; Günther S; Scandella E; Drosten C; Bai D; He X; Ludewig B; Chen J; Luo H; Yang Y; Yang Y; Zou J; Thiel V; Chen K; Shen J; Shen X; Jiang H
J Virol; 2005 Jun; 79(11):7095-103. PubMed ID: 15890949
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors.
Chen LR; Wang YC; Lin YW; Chou SY; Chen SF; Liu LT; Wu YT; Kuo CJ; Chen TS; Juang SH
Bioorg Med Chem Lett; 2005 Jun; 15(12):3058-62. PubMed ID: 15896959
[TBL] [Abstract][Full Text] [Related]
4. Discovering severe acute respiratory syndrome coronavirus 3CL protease inhibitors: virtual screening, surface plasmon resonance, and fluorescence resonance energy transfer assays.
Chen L; Chen S; Gui C; Shen J; Shen X; Jiang H
J Biomol Screen; 2006 Dec; 11(8):915-21. PubMed ID: 17092912
[TBL] [Abstract][Full Text] [Related]
5. Discovery of potent anilide inhibitors against the severe acute respiratory syndrome 3CL protease.
Shie JJ; Fang JM; Kuo CJ; Kuo TH; Liang PH; Huang HJ; Yang WB; Lin CH; Chen JL; Wu YT; Wong CH
J Med Chem; 2005 Jun; 48(13):4469-73. PubMed ID: 15974598
[TBL] [Abstract][Full Text] [Related]
6. New developments for the design, synthesis and biological evaluation of potent SARS-CoV 3CL(pro) inhibitors.
Regnier T; Sarma D; Hidaka K; Bacha U; Freire E; Hayashi Y; Kiso Y
Bioorg Med Chem Lett; 2009 May; 19(10):2722-7. PubMed ID: 19362479
[TBL] [Abstract][Full Text] [Related]
7. Structure-based design and synthesis of highly potent SARS-CoV 3CL protease inhibitors.
Shao YM; Yang WB; Peng HP; Hsu MF; Tsai KC; Kuo TH; Wang AH; Liang PH; Lin CH; Yang AS; Wong CH
Chembiochem; 2007 Sep; 8(14):1654-7. PubMed ID: 17722121
[No Abstract] [Full Text] [Related]
8. Synthesis, docking studies, and evaluation of pyrimidines as inhibitors of SARS-CoV 3CL protease.
Ramajayam R; Tan KP; Liu HG; Liang PH
Bioorg Med Chem Lett; 2010 Jun; 20(12):3569-72. PubMed ID: 20494577
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of a series of serine derivatives as small molecule inhibitors of the SARS coronavirus 3CL protease.
Konno H; Wakabayashi M; Takanuma D; Saito Y; Akaji K
Bioorg Med Chem; 2016 Mar; 24(6):1241-54. PubMed ID: 26879854
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease.
Shao YM; Yang WB; Kuo TH; Tsai KC; Lin CH; Yang AS; Liang PH; Wong CH
Bioorg Med Chem; 2008 Apr; 16(8):4652-60. PubMed ID: 18329272
[TBL] [Abstract][Full Text] [Related]
11. Inhibitor design for SARS coronavirus main protease based on "distorted key theory".
Du QS; Sun H; Chou KC
Med Chem; 2007 Jan; 3(1):1-6. PubMed ID: 17266617
[TBL] [Abstract][Full Text] [Related]
12. Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors for the severe acute respiratory syndrome-coronavirus papain-like protease.
Ghosh AK; Takayama J; Aubin Y; Ratia K; Chaudhuri R; Baez Y; Sleeman K; Coughlin M; Nichols DB; Mulhearn DC; Prabhakar BS; Baker SC; Johnson ME; Mesecar AD
J Med Chem; 2009 Aug; 52(16):5228-40. PubMed ID: 19645480
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a novel family of SARS-CoV protease inhibitors by virtual screening and 3D-QSAR studies.
Tsai KC; Chen SY; Liang PH; Lu IL; Mahindroo N; Hsieh HP; Chao YS; Liu L; Liu D; Lien W; Lin TH; Wu SY
J Med Chem; 2006 Jun; 49(12):3485-95. PubMed ID: 16759091
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV.
Hsu JT; Kuo CJ; Hsieh HP; Wang YC; Huang KK; Lin CP; Huang PF; Chen X; Liang PH
FEBS Lett; 2004 Sep; 574(1-3):116-20. PubMed ID: 15358550
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors.
Ramajayam R; Tan KP; Liu HG; Liang PH
Bioorg Med Chem; 2010 Nov; 18(22):7849-54. PubMed ID: 20947359
[TBL] [Abstract][Full Text] [Related]
16. Development of a red-shifted fluorescence-based assay for SARS-coronavirus 3CL protease: identification of a novel class of anti-SARS agents from the tropical marine sponge Axinella corrugata.
Hamill P; Hudson D; Kao RY; Chow P; Raj M; Xu H; Richer MJ; Jean F
Biol Chem; 2006 Aug; 387(8):1063-74. PubMed ID: 16895476
[TBL] [Abstract][Full Text] [Related]
17. High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase.
Blanchard JE; Elowe NH; Huitema C; Fortin PD; Cechetto JD; Eltis LD; Brown ED
Chem Biol; 2004 Oct; 11(10):1445-53. PubMed ID: 15489171
[TBL] [Abstract][Full Text] [Related]
18. Maturation mechanism of severe acute respiratory syndrome (SARS) coronavirus 3C-like proteinase.
Li C; Qi Y; Teng X; Yang Z; Wei P; Zhang C; Tan L; Zhou L; Liu Y; Lai L
J Biol Chem; 2010 Sep; 285(36):28134-40. PubMed ID: 20489209
[TBL] [Abstract][Full Text] [Related]
19. Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease.
Lu IL; Mahindroo N; Liang PH; Peng YH; Kuo CJ; Tsai KC; Hsieh HP; Chao YS; Wu SY
J Med Chem; 2006 Aug; 49(17):5154-61. PubMed ID: 16913704
[TBL] [Abstract][Full Text] [Related]
20. Discovery of unsymmetrical aromatic disulfides as novel inhibitors of SARS-CoV main protease: Chemical synthesis, biological evaluation, molecular docking and 3D-QSAR study.
Wang L; Bao BB; Song GQ; Chen C; Zhang XM; Lu W; Wang Z; Cai Y; Li S; Fu S; Song FH; Yang H; Wang JG
Eur J Med Chem; 2017 Sep; 137():450-461. PubMed ID: 28624700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
